What are 5-HT1F receptor agonist drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

5-HT1F receptor agonist drugs are pharmacologic agents that share a common mechanism (typically targeting 5-HT1F receptor). 0 are currently marketed, with 2 more in clinical development.

5-HT1F receptor agonist

0 marketed 2 in Phase 3

This page covers all 5-HT1F receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT1F receptor.

Targets

5-HT1F receptor

Phase 3 pipeline (2)

BHV-4157 · Biohaven Therapeutics Ltd. · Neurology
BHV-4157 is a selective serotonin 5-HT1F receptor agonist that reduces neuronal activity and neuropeptide release to treat acute migraine.
NP101 · NuPathe Inc. · Neurology
NP101 is a selective serotonin 5-HT1F receptor agonist that reduces migraine pain by constricting cranial blood vessels and inhibiting neuropeptide release.

Patent intelligence

5 ht1f receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates